Adapting a cold intolerance assessment tool for Dutch-speaking patients with hand injuries
Ciss-DLV-Cross-cultural Adaptation of the 'Cold Intolerance Severity Score' (CISS) to the Dutch Language.
This study is trying to adapt a questionnaire about cold intolerance for Dutch-speaking patients with hand injuries to make sure it accurately reflects their experiences.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Sex | All |
| Sponsor | Erasmus Medical Center Academic / other |
| Locations | 1 site (Rotterdam, Zuid-Holland) |
| Trial ID | NCT05925907 on ClinicalTrials.gov |
What this trial studies
This study aims to adapt the Cold Intolerance Severity Score (CISS) for Dutch-speaking patients who have experienced hand injuries. It focuses on translating and validating the CISS to ensure it accurately reflects the experiences of patients in medicolegal contexts. The methodology includes multiple forward and back translations by native speakers to maintain the integrity of the questionnaire. The goal is to report cold intolerance levels in these patients and explore the feasibility of a shorter version of the CISS questionnaire.
Who should consider this trial
Good fit: Ideal candidates for this study are adults with traumatic hand injuries who have sufficient knowledge of the Dutch language.
Not a fit: Patients who have experienced definitive total hand amputation may not benefit from this study.
Why it matters
Potential benefit: If successful, this adaptation could provide a reliable tool for assessing cold intolerance in Dutch-speaking patients, leading to better understanding and management of their symptoms.
How similar studies have performed: While the adaptation of assessment tools is common, this specific adaptation for the CISS in the Dutch language is a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * - Adult * Traumatic hand injury * Sufficient knowledge of the Dutch language (at least level B1) Exclusion Criteria: * - Definitive total hand amputation
Where this trial is running
Rotterdam, Zuid-Holland
- Erasmuc MC — Rotterdam, Zuid-Holland, Netherlands (Recruiting)
Study contacts
- Principal investigator: Reinier Feitz, MD PhD — Erasmus Medical Center
- Study coordinator: Reinier Feitz, MD PhD
- Email: info@handcentrum.nl
- Phone: 0303200556
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.